Effect of MK-458 (HPMC) in Parkinsonʼs Disease Previously Untreated With Dopaminergic Drugs. A Double-Blind, Placebo-Controlled Multicenter Study
Koller, W. C., Block, G. A., Ahlskog, J. E., Ahrens, S., Cedarbaum, J. M., Cyhan, G., Goetz, C. G., LeWitt, P. A., Liss, C., McLean, L., Moses, H., Muenter, M. D., Nausieda, P., Sanchez-Ramos, J., ReiVolume:
14
Journal:
Clinical Neuropharmacology
DOI:
10.1097/00002826-199108000-00004
Date:
August, 1991
File:
PDF, 392 KB
1991